Retraction: A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer. N Engl J Med 2006;355:570-80.

  • Potti A
  • Mukherjee S
  • Petersen R
  • et al.
18Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

To the Editor: We would like to retract our article, "A Genomic Strategy to Refine Prognosis in Early-Stage Non-Small-Cell Lung Cancer,"(1) which was published in the Journal on August 10, 2006. Using a sample set from a study by the American College of Surgeons Oncology Group (ACOSOG) and a collection of samples from a study by the Cancer and Leukemia Group B (CALGB), we have tried and failed to reproduce results supporting the validation of the lung metagene model described in the article. We deeply regret the effect of this action on the work of other investigators.

Cite

CITATION STYLE

APA

Potti, A., Mukherjee, S., Petersen, R., Dressman, H. K., Bild, A., Koontz, J., … Nevins, J. R. (2011). Retraction: A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer. N Engl J Med 2006;355:570-80. New England Journal of Medicine, 364(12), 1176–1176. https://doi.org/10.1056/nejmc1101915

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free